0.05Open0.05Pre Close10 Volume19 Open Interest2.50Strike Price50.00Turnover551.89%IV348.15%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier14DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.2168Delta0.4660Gamma11.40Leverage Ratio-0.0063Theta0.0000Rho2.47Eff Leverage0.0003Vega
Beyond Air Stock Discussion
Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Beyond Cancer, , a clinical stage biotechnology company, has been selected to present two poster presentations at the upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024. The event is scheduled for November 6-10 at the George R. Brown Convention Center in Houston, Texas. The ...
5 MINUTES AGO, 7:30 AM EDT
VIA GLOBENEWSWIRE
Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules
– Financing strengthens balance sheet and is expected to provide sufficient cash runway through June 2026 –
– Retiring $17.5 million in Avenue Capital debt, aided by $11.5 million in new debt from insider-led group; eliminates $12 million in scheduled debt payments through June 2026 –
– Avenue Capital, current insiders, and select group of healthcare-focuse...
No comment yet